Comment from Crompton Michael
AnonymousSupportIndividual
Summary: The commenter, a patient who uses peptides, supports the creation of a regulated pathway for compounded peptides. They argue that providing a safe, regulated option will improve patient safety, lower costs, and keep patients out of unregulated markets.
I am writing to support patient and physician access to safe, regulated compounded peptides.
i have used peptides for a dacade and evertime i order im gambeling i would love for there to be american made peptides
Compounded peptides, prepared by accredited pharmacies under state and federal oversight, give physicians and pharmacists important tools to care for their patients. Restricting access pushes patients toward an unregulated market and raises costs, which disproportionately affects people managing chronic conditions.
I urge the committee to support a safe, quality, and regulated pathway for these peptides so that the patient-provider relationship is preserved and care stays in accountable channels.
Thank you for considering my comment.